-
Pediatric Leukemia ‘Super Drug’ Could be Developed in Coming Years
Northwestern Medicine scientists have discovered two successful therapies that slowed the progression of pediatric leukemia in mice, the first step towards a pediatric leukemia “super drug.”
-
Two Type 2 Diabetes Drugs Linked to Higher Risk of Heart Disease
Two drugs commonly prescribed to treat Type 2 diabetes carry a high risk of cardiovascular events such as heart attack, stroke, heart failure or amputation, according to a new Northwestern Medicine study.
-
Alumnus David Skorton Named President of AAMC
Alumnus David Skorton, ‘74 MD, secretary of the Smithsonian Institution, has been named the president and CEO of the Association of American Medical Colleges.
-
Drug Regimen Improves Survival in Lymphoma
A drug called brentuximab vedotin combined with chemotherapy significantly improved overall survival for patients with a type of T-cell lymphoma, according to a clinical trial in The Lancet.
-
Remembering Laszlo Lorand, PhD, Professor Emeritus of Cell and Molecular Biology
Laszlo Lorand, PhD, professor emeritus of Cell and Molecular Biology and a distinguished scientist whose career spanned more than 60 years at Northwestern, passed away on December 6.
-
Healthcare Professionals Lend a Hand in Honduras
Northwestern Medicine professionals treated nearly 1,000 patients as part of a medical mission trip in late September.
-
Resilience May Be Neurobiological
A new study aims to answer a resilience puzzle: Why second-hand experiences of neighborhood violence affect some youth, but not others.
-
New Understanding of Enzyme’s Role in Prostate Cancer
Northwestern Medicine scientists have discovered that an enzyme called EZH2 can activate expression of the androgen receptor gene, which drives prostate cancer growth.
-
Ebola-Fighting Protein Discovered
A human protein called RBBP6 helps fight the Ebola virus by interfering with the virus replication cycle, according to a study recently published in Cell.
-
Inflammatory Bowel Disease Linked to Prostate Cancer
Men with inflammatory bowel disease have four to five times higher risk of prostate cancer, according to a new 20-year study.
-
New Regulator of Leukemia Discovered
Inhibiting CHAF1B, a protein that normally helps replenish blood cells, may be a promising treatment for leukemia, according to a recent study.
-
New Associate Dean for Faculty Development Named
Farzaneh Sorond, MD, PhD, has been named the new associate dean for Faculty Development for Northwestern University Feinberg School of Medicine.
-
IPHAM Hosts Inaugural Population Health Forum
Feinberg faculty, staff, students and community partners gathered at the inaugural IPHAM Population Health Forum to share their experience improving the health of communities in Chicago and around the world.
-
Celebrating Our 2018 Discoveries
From fundamental new understandings of the cell published in Nature to landmark clinical trials in the New England Journal of Medicine and cross-disciplinary collaborations in Science Translational Medicine, investigators throughout our institution have advanced new knowledge that is already transforming their diverse fields.
-
Public Health Panel Discusses World AIDS Day
Northwestern scientists specializing in HIV and AIDS gathered to share their experiences during a panel held December 3, to commemorate World AIDS Day.
-
World’s Smallest Wearable Device Warns of UV Exposure, Enables Precision Phototherapy
The world’s smallest wearable device has been developed by Northwestern scientists, to measure exposure to light across multiple wavelengths.
-
New Therapeutic Target Identified in Prostate Cancer
A Northwestern Medicine study has revealed new insights into a pathway in prostate cancer and identified a potential new therapeutic target for aggressive disease.
-
Student Variety Show Raises Money to Fight Homelessness
The 40th performance of In Vivo, Feinberg students’ annual sketch comedy and variety show, raised money for a Chicago-area charity that helps homeless women.
-
Incorporating Virtual Reality Into Medical Education
Patricia Garcia, MD, MPH, ’91 GME, associate dean for curriculum, discussed the use of augmented, virtual and mixed reality in medical education during a recent Today’s Innovations in Medical Education lecture.
-
New Insights Into Reward-Motivated Behavior
The ventral striatum, a small part of the brain’s basal ganglia, directs behavior by assigning a reward dimension to everyday items, according to a recent study.
